Published by Coherent Market Insights
Posted on September 30, 2021
5 min readLast updated: February 1, 2026
The contraceptives market is set to grow at a 5.5% CAGR by 2027, driven by advanced options and increased awareness among women.
Contraceptives Drugs And Devices Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Contraceptives Drugs And Devices Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/365
Note: *The Sample only consist of Table of Content (ToC), Research Framework of the actual report, and Research Methodology adopted for it.
Major Players In This Market Are: Evofem Biosciences, Inc., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Uniprix, Gavis Pharmaceuticals (Lupin Limited), Sandoz International GmbH, Aurobindo Pharma Limited, HRA Pharma, SA, Mankind Pharma, Merck & Co, Bayer HealthCare AG, Church & Dwight, Co. Inc., Allergan, Pfizer, Inc., Agile Therapeutics Inc., BioSante Pharmaceuticals Inc., Mayer Laboratories, Inc., and Pantarhei Bioscience B.V.
Market Overview:
Oral contraceptives (birth-control pills) are used to prevent pregnancy. Contraceptives drugs and devices help avoid unplanned pregnancy. Intrauterine method, emergency contraception, barrier method, hormonal method, and sterilization are five widely used contraceptive methods. Sterilization is the most common method implemented globally. While, contraceptive devices include oral pills, female condoms, vaginal rings, intra-uterine devices (IUD), and diaphragms. Selecting the most appropriate drug and device is critical to avoid undesired side effects. Both contraceptives drugs and devices offer protection against pregnancy by blocking the union of sperm and egg, preventing conception. Thus, there is an increasing demand for contraceptives drugs and devices in the United States.
Key Market Drivers:
Increasing demand for advanced contraceptive options is expected to drive growth of the U.S. contraceptives drugs and devices market during the forecast period. For instance, in April 2021, Mayne Pharma announced that the U.S. Food and Drug Administration (FDA) has approved (safe and effective) NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy.
Moreover, increasing awareness among women about contraceptives drugs and devices is also expected to boost the growth of the U.S. contraceptives drugs and devices market. For instance, according to the World Health Organization (WHO), emergency contraception can prevent up to over 95% of pregnancies when taken within 5 days after intercourse.
COVID-19 Impact Analysis:
Around 3.6 million babies were born in the United States in 2020. According the Centers for Diseases Control and Prevention (CDC), the U.S. birth rate fell for the sixth year in a row in 2020. Moreover, the researchers found that 65.3 percent of women aged 15 to 49 years in the United States used contraception in 2017 to 2019. Oral contraceptive pills, female sterilization, male condoms, and long-acting reversible contraceptives (LARCs) are the most commonly used contraceptive methods. Furthermore, a California law gives women access to birth control without a doctor’s prescription by allowing pharmacists to prescribe instead. This in turn is expected to aid in the growth of the U.S. contraceptives drugs and devices market.
Key Takeaways:
The U.S. contraceptives drugs and devices market is expected to exhibit a CAGR of XX % during the forecast period due to the increase in development and introduction of novel contraceptives drugs and devices. For instance, in 2018, Lupin announced the launch of Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets and Levomefolate Calcium tablets, used to prevent pregnancy, in the US market, following the USFDA approval. Moreover, in August 2018, FDA approved new vaginal ring for one year of birth control. Annovera is the first vaginal ring contraceptive that can be used for an entire year.
Among region, New York is expected to witness a strong growth in the U.S. contraceptives drugs and devices market owing to rise in government initiatives to promote the use of contraceptives. For instance, in 2019, the Department of Financial Services (DFS) issued a circular letter to remind and instruct insurers about their responsibilities under the new Comprehensive Contraceptive Coverage Act (CCCA).
Buy This Premium Report Of Contraceptives Drugs And Devices Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/365
In this study, the years considered to estimate the market size of Contraceptives Drugs And Devices are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Contraceptives Drugs And Devices Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Contraceptives Drugs And Devices Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Contraceptives Drugs And Devices Market is Estimated to Expand its Size at a CAGR of 5.5 % till 2027 | Top Key Vendors, SWOT Analysis, Regional Revenue, Strategy Profiling, Growth Drivers and Upcoming Trends appeared first on Gatorledger.
The main topic is the growth and analysis of the contraceptives drugs and devices market projected until 2027.
Advanced contraceptive options and increased awareness among women are key drivers of market growth.
Major players include Evofem Biosciences, Teva Pharmaceutical, and Bayer HealthCare.
Explore more articles in the Research Reports category
